Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status

Epigenetics

Volumn 8, Issue 12, 2013, Pages 1289-1302

  Houde, Andrée Anne ^a,b   Guay, Simon Pierre ^a,b   Desgagné, Véronique ^a,b   Hivert, Marie France ^c,d   Baillargeon, Jean Patrice ^c   St Pierre, Julie ^b,e   Perron, Patrice ^b,c   Gaudet, Daniel ^b,f   Brisson, Diane ^b,f   Bouchard, Luigi ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b CHICOUTIMI HOSPITAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Epigenetics; Fetal programming; Gestational diabetes; High density lipoprotein cholesterol; Lipid metabolism

Indexed keywords

ABC TRANSPORTER A1; C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOPSY; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; MATERNAL AGE; METABOLISM; NEWBORN; PLACENTA; PYROSEQUENCING; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

EPIGENETICS; FETAL PROGRAMMING; GESTATIONAL DIABETES; HIGH-DENSITY LIPOPROTEIN CHOLESTEROL; LIPID METABOLISM;

ADULT; ATP BINDING CASSETTE TRANSPORTER 1; CHOLESTEROL, HDL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETAL BLOOD; GLUCOSE INTOLERANCE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; METABOLISM; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; TRIGLYCERIDES;

EID: 84888811208     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26554     Document Type: Article

References (58)

1. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71(Suppl):1256S-61S; PMID:10799399
2. Galtier F. Definition, epidemiology, risk factors. Diabetes Metab 2010; 36:628-51; PMID:21163426; http://dx.doi.org/10.1016/j.diabet.2010.11.014
3. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30:2287-92; PMID:17519427; http://dx.doi.org/10.2337/ dc06-2361
4. Dabelea D, Mayer-Davis EJ, Lamichhane AP, D'Agostino RB Jr., Liese AD, Vehik KS, Narayan KM, Zeitler P, Hamman RF. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care 2008; 31:1422-6; PMID:18375420; http://dx.doi.org/10.2337/dc07-2417
5. Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, Schmidt L, Damm P. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab 2009; 94:2464-70; PMID:19417040; http:// dx.doi.org/10.1210/jc.2009-0305
6. Barker DJ. Intrauterine programming of adult disease. Mol Med Today 1995; 1:418-23; PMID:9415190; http://dx.doi.org/10.1016/S1357-4310(95)90793-9
7. Lillycrop KA, Burdge GC. Epigenetic changes in early life and future risk of obesity. Int J Obes (Lond) 2011; 35:72-83; PMID:20548303; http://dx.doi. org/10.1038/ijo.2010.122
8. Henikoff S, Matzke MA. Exploring and explaining epigenetic effects. Trends Genet 1997; 13:293-5; PMID:9260513; http://dx.doi.org/10.1016/ S0168-9525(97)01219-5
9. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21; PMID:11782440; http://dx.doi.org/10.1101/gad.947102
10. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9:2395-402; PMID:11005794; http://dx.doi.org/10.1093/ hmg/9.16.2395
11. Bouchard L, Hivert MF, Guay SP, St-Pierre J, Perron P, Brisson D. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes 2012; 61:1272-80; PMID:22396200; http://dx.doi.org/10.2337/ db11-1160
12. Bouchard L, Thibault S, Guay SP, Santure M, Monpetit A, St-Pierre J, Perron P, Brisson D. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care 2010; 33:2436-41; PMID:20724651; http://dx.doi. org/10.2337/dc10-1024
13. El Hajj N, Pliushch G, Schneider E, Dittrich M, Müller T, Korenkov M, Aretz M, Zechner U, Lehnen H, Haaf T. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 2013; 62:1320-8; PMID:23209187; http://dx.doi.org/10.2337/ db12-0289
14. Kim ES, Isoda F, Kurland I, Mobbs CV. Glucose-Induced Metabolic Memory in Schwann Cells: Prevention by PPAR Agonists. Endocrinology 2013; 154:3054-66; PMID:23709088; http://dx.doi. org/10.1210/en.2013-1097
15. Turan N, Ghalwash MF, Katari S, Coutifaris C, Obradovic Z, Sapienza C. DNA methylation differences at growth related genes correlate with birth weight: a molecular signature linked to developmental origins of adult disease? BMC Med Genomics 2012; 5:10; PMID:22498030; http:// dx.doi.org/10.1186/1755-8794-5-10
16. Yuen RK, Avila L, Peñaherrera MS, von Dadelszen P, Lefebvre L, Kobor MS, Robinson WP. Human placental-specific epipolymorphism and its association with adverse pregnancy outcomes. PLoS One 2009; 4:e7389; PMID:19838307; http://dx.doi. org/10.1371/journal.pone.0007389
17. Filiberto AC, Maccani MA, Koestler D, Wilhelm-Benartzi C, Avissar-Whiting M, Banister CE, Gagne LA, Marsit CJ. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 2011; 6:566-72; PMID:21521940; http://dx.doi.org/10.4161/ epi.6.5.15236
18. Ferreira JC, Choufani S, Grafodatskaya D, Butcher DT, Zhao C, Chitayat D, Shuman C, Kingdom J, Keating S, Weksberg R. WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate. Epigenetics 2011; 6:440-9; PMID:21474991; http://dx.doi. org/10.4161/epi.6.4.14554
19. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C, Rodford J, Slater-Jefferies JL, Garratt E, Crozier SR, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011; 60:1528-34; PMID:21471513; http://dx.doi.org/10.2337/ db10-0979
20. Seki Y, Williams L, Vuguin PM, Charron MJ. Minireview: Epigenetic programming of diabetes and obesity: animal models. Endocrinology 2012; 153:1031-8; PMID:22253432; http://dx.doi. org/10.1210/en.2011-1805
21. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008; 105:17046-9; PMID:18955703; http:// dx.doi.org/10.1073/pnas.0806560105
22. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific. Hum Mol Genet 2009; 18:4046-53; PMID:19656776; http://dx.doi.org/10.1093/hmg/ ddp353
23. Joyce C, Freeman L, Brewer HB Jr., Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol 2003; 23:965-71; PMID:12615681; http://dx.doi.org/10.1161/01. ATV.0000055194.85073.FF
24. Albrecht C, Soumian S, Tetlow N, Patel P, Sullivan MH, Lakasing L, Nicolaides K, Williamson C. Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to preeclampsia and controls. Placenta 2007; 28:701-8; PMID:17113147; http://dx.doi.org/10.1016/j. placenta.2006.10.001
25. Nikitina L, Wenger F, Baumann M, Surbek D, Körner M, Albrecht C. Expression and localization pattern of ABCA1 in diverse human placental primary cells and tissues. Placenta 2011; 32:420-30; PMID:21501868; http://dx.doi.org/10.1016/j.placenta.2011.03.003
26. Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D, Bouchard L. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 2012; 7:464-72; PMID:22419126; http://dx.doi.org/10.4161/ epi.19633
27. van der Graaf A, Vissers MN, Gaudet D, Brisson D, Sivapalaratnam S, Roseboom TJ, Jansen AC, Kastelein JJ, Hutten BA. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring. Arterioscler Thromb Vasc Biol 2010; 30:2673-7; PMID:20864670; http://dx.doi. org/10.1161/ATVBAHA.110.209064
28. DeRuiter MC, Alkemade FE, Gittenberger-de Groot AC, Poelmann RE, Havekes LM, van Dijk KW. Maternal transmission of risk for atherosclerosis. Curr Opin Lipidol 2008; 19:333-7; PMID:18607178; http://dx.doi.org/10.1097/MOL.0b013e328304b670
29. Deveer R, Deveer M, Akbaba E, Engin-Üstün Y, Aydogan P, Celikkaya H, Danisman N, Mollamahmutoglu L. The effect of diet on pregnancy outcomes among pregnant with abnormal glucose challenge test. Eur Rev Med Pharmacol Sci 2013; 17:1258-61; PMID:23690197
30. Stewart ZA, Wallace EM, Allan CA. Patterns of weight gain in pregnant women with and without gestational diabetes mellitus: an observational study. Aust N Z J Obstet Gynaecol 2012; 52:433-9; PMID:23045986; http://dx.doi.org/10.1111/ ajo.12001
31. Walsh JM, Mahony R, Byrne J, Foley M, McAuliffe FM. The association of maternal and fetal glucose homeostasis with fetal adiposity and birthweight. Eur J Obstet Gynecol Reprod Biol 2011; 159:338-41; PMID:21982556; http://dx.doi.org/10.1016/j. ejogrb.2011.09.022
32. Deierlein AL, Siega-Riz AM, Chantala K, Herring AH. The association between maternal glucose concentration and child BMI at age 3 years. Diabetes Care 2011; 34:480-4; PMID:21216858; http:// dx.doi.org/10.2337/dc10-1766
33. Clausen T, Burski TK, Øyen N, Godang K, Bollerslev J, Henriksen T. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 2005; 153:887-94; PMID:16322395; http://dx.doi.org/10.1530/ eje.1.02034
34. Misra VK, Trudeau S, Perni U. Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring) 2011; 19:1476-81; PMID:21394096; http:// dx.doi.org/10.1038/oby.2011.43
35. Palinski W, Yamashita T, Freigang S, Napoli C. Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Rev 2007; 65:S182-7; PMID:18240546; http://dx.doi. org/10.1301/nr.2007.dec.S182-S187
36. Baardman ME, Kerstjens-Frederikse WS, Berger RM, Bakker MK, Hofstra RM, Plösch T. The role of maternal-fetal cholesterol transport in early fetal life: current insights. Biol Reprod 2013; 88:24; PMID:23153566; http://dx.doi.org/10.1095/ biolreprod.112.102442
37. Aye IL, Waddell BJ, Mark PJ, Keelan JA. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity. Biochim Biophys Acta 2010; 1801:1013-24; PMID:20570635; http://dx.doi.org/10.1016/j. bbalip.2010.05.015
38. Dubé E, Ethier-Chiasson M, Lafond J. Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta. Biol Reprod 2013; 88:16; PMID:23221398; http:// dx.doi.org/10.1095/biolreprod.112.105619
39. Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, Marsche G, Sadjak A, Lang U, Desoye G, et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res 2009; 104:600-8; PMID:19168441; http://dx.doi. org/10.1161/CIRCRESAHA.108.185066
40. Palinski W. Maternal-fetal cholesterol transport in the placenta: good, bad, and target for modulation. Circ Res 2009; 104:569-71; PMID:19286612; http:// dx.doi.org/10.1161/CIRCRESAHA.109.194191
41. nd, Lee A, Cerjak D, Ali O, Diasio R, Olivier M, Blangero J, Carless MA, Kissebah AH. Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population. BMC Med Genomics 2013; 6:9; PMID:23510163; http:// dx.doi.org/10.1186/1755-8794-6-9
42. Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, Mangino M, Zhai G, Zhang F, Valdes A, et al.; MuTHER Consortium. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet 2012; 8:e1002629; PMID:22532803; http://dx.doi.org/10.1371/journal.pgen.1002629
43. Lesseur C, Armstrong DA, Paquette AG, Koestler DC, Padbury JF, Marsit CJ. Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol 2013; 381:160-7; PMID:23911897; http://dx.doi.org/10.1016/j.mce.2013.07.024
44. Fowden AL, Sferruzzi-Perri AN, Coan PM, Constancia M, Burton GJ. Placental efficiency and adaptation: endocrine regulation. J Physiol 2009; 587:3459-72; PMID:19451204; http://dx.doi. org/10.1113/jphysiol.2009.173013
45. Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006; 108:644-50; PMID:16946226; http://dx.doi.org/10.1097/01. AOG.0000231688.08263.47
46. Bunt JC, Tataranni PA, Salbe AD. Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children. J Clin Endocrinol Metab 2005; 90:3225-9; PMID:15797952; http://dx.doi.org/10.1210/ jc.2005-0007
47. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115:e290-6; PMID:15741354; http://dx.doi.org/10.1542/peds.2004-1808
48. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka JM, van Montfrans GA, Michels RP, Bleker OP. Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45. Heart 2000; 84:595-8; PMID:11083734; http:// dx.doi.org/10.1136/heart.84.6.595
49. Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Twin Res 2001; 4:293-8; PMID:11869479
50. Hinault C, Van Obberghen E, Mothe-Satney I. Role of amino acids in insulin signaling in adipocytes and their potential to decrease insulin resistance of adipose tissue. J Nutr Biochem 2006; 17:374-8; PMID:16644198; http://dx.doi.org/10.1016/j. jnutbio.2006.02.008
51. Lohman TG. RAaMR. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books, 1988.
52. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502; PMID:4337382
53. Ahima RS. Digging deeper into obesity. J Clin Invest 2011; 121:2076-9; PMID:21633174; http://dx.doi. org/10.1172/JCI58719
54. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9; PMID:3899825; http://dx.doi.org/10.1007/ BF00280883
55. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11:541-8; PMID:1239396; http://dx.doi. org/10.1007/BF01222104
56. Meller M, Vadachkoria S, Luthy DA, Williams MA. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 2005; 26:601-7; PMID:16085039; http://dx.doi. org/10.1016/j.placenta.2004.09.009
57. Murthi P, Fitzpatrick E, Borg AJ, Donath S, Brennecke SP, Kalionis B. GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta 2008; 29:798-801; PMID:18684503; http://dx.doi.org/10.1016/j.placenta.2008.06.007
58. Drewlo S, Levytska K, Kingdom J. Revisiting the housekeeping genes of human placental development and insufficiency syndromes. Placenta 2012; 33:952-4; PMID:23026742; http://dx.doi.org/10.1016/j. placenta.2012.09.007